Structure-based design of novel bicyclic nonpeptide inhibitors for the Src SH2 domain

被引：27
|
作者：
Shakespeare, WC [1 ]
Bohacek, RS [1 ]
Azimioara, MD [1 ]
Macek, KJ [1 ]
Luke, GP [1 ]
Dalgarno, DC [1 ]
Hatada, MH [1 ]
Lu, XD [1 ]
Violette, SM [1 ]
Bartlett, C [1 ]
Sawyer, TK [1 ]
机构：
[1] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2000年 / 43卷 / 21期
关键词：
D O I：
10.1021/jm0003337
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：3815 / 3819
页数：5
相关论文
共 50 条
  • [21] Potent nonpeptide Src SH2 inhibitors designed from a novel heterocyclic scaffold: Modifications of phosphotyrosine and structure-activity studies.
    Deprez, P
    Mandine, EF
    Bardelay, C
    Botham, RP
    Delettre, G
    Lange, G
    Humbert, J
    Massardier, D
    Schoot, B
    Vermond, A
    Viet, S
    Sarubbi, E
    Kawahata, N
    Yang, M
    Jacobsen, V
    Bohacek, R
    Dalgarno, D
    Sawyer, T
    Weigele, M
    Gaillard, M
    Baron, R
    Lesuisse, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S517 - S517
  • [22] BINDING OF THE SRC SH2 DOMAIN TO PHOSPHOPEPTIDES IS DETERMINED BY RESIDUES IN BOTH THE SH2 DOMAIN AND THE PHOSPHOPEPTIDES
    BIBBINS, KB
    BOEUF, H
    VARMUS, HE
    MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) : 7278 - 7287
  • [23] A photoactivatable Src homology 2 (SH2) domain
    Song, X.
    Shang, X.
    Ju, T.
    Cerny, R.
    Niu, W.
    Guo, J.
    RSC ADVANCES, 2016, 6 (56): : 51120 - 51124
  • [24] Design and synthesis of non-peptidic inhibitors for the Syk C-terminal SH2 domain based on structure-based in-silico screening
    Niimi, T
    Orita, M
    Okazawa-Igarashi, M
    Sakashita, H
    Kikuchi, K
    Ball, E
    Ichikawa, A
    Yamagiwa, Y
    Sakamoto, S
    Tanaka, A
    Tsukamoto, S
    Fujita, S
    Tatsuta, K
    Maeda, Y
    Chikauchi, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) : 4737 - 4740
  • [25] Novel phosphotyrosine mimetics in the design of peptide ligands for pp60(src) SH2 domain
    Shahripour, A
    Plummer, MS
    Lunney, EA
    Para, KS
    Stankovic, CJ
    Rubin, JR
    Humblet, C
    Fergus, JH
    Marks, JS
    Herrera, R
    Hubbell, SE
    Saltiel, AR
    Sawyer, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (11) : 1209 - 1214
  • [26] Design of peptidomimetic ligands for the pp60(src) SH2 domain
    Plummer, MS
    Lunney, EA
    Para, KS
    Shahripour, A
    Stankovic, CJ
    Humblet, C
    Fergus, JH
    Marks, JS
    Herrera, R
    Hubbell, S
    Saltiel, A
    Sawyer, TK
    BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (01) : 41 - 47
  • [27] Discovery of novel de novo designed synthetic, small-molecule, nonpeptide ligands that bind to the Src homology (SH2) domain
    Para, KS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 46 - ORGN
  • [28] Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: Implications for drug design
    Taylor, Jonathan D.
    Ababou, Abdessamad
    Fawaz, Radwan R.
    Hobbs, Christopher J.
    Williams, Mark A.
    Ladbury, John E.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 73 (04) : 929 - 940
  • [29] Potent dipeptide inhibitors of the pp60c-src SH2 domain
    Pacofsky, GJ
    Lackey, K
    Alligood, KJ
    Berman, J
    Charifson, PS
    Crosby, RM
    Dorsey, GF
    Feldman, PL
    Gilmer, TM
    Hummel, CW
    Jordan, SR
    Mohr, C
    Shewchuk, LM
    Sternbach, DD
    Rodriguez, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) : 1894 - 1908
  • [30] Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility
    Kong, Ren
    Bharadwaj, Uddalak
    Eckols, T. Kris
    Kolosov, Mikhail
    Wu, Haoyi
    Cruz-Pavlovich, Francisco J. Santa
    Shaw, Alison
    Ifelayo, Oluwatomilona I.
    Zhao, Hong
    Kasembeli, Moses M.
    Wong, Stephen T. C.
    Tweardy, David J.
    PHARMACOLOGICAL RESEARCH, 2021, 169
12345